97 related articles for article (PubMed ID: 13679179)
1. Towards new neuroprotective agents: design and synthesis of 4H-thieno[2,3-c] isoquinolin-5-one derivatives as potent PARP-1 inhibitors.
Pellicciari R; Camaioni E; Costantino G; Marinozzi M; Macchiarulo A; Moroni F; Natalini B
Farmaco; 2003 Sep; 58(9):851-8. PubMed ID: 13679179
[TBL] [Abstract][Full Text] [Related]
2. Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia.
Chiarugi A; Meli E; Calvani M; Picca R; Baronti R; Camaioni E; Costantino G; Marinozzi M; Pellegrini-Giampietro DE; Pellicciari R; Moroni F
J Pharmacol Exp Ther; 2003 Jun; 305(3):943-9. PubMed ID: 12606624
[TBL] [Abstract][Full Text] [Related]
3. 5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2).
Sunderland PT; Woon EC; Dhami A; Bergin AB; Mahon MF; Wood PJ; Jones LA; Tully SR; Lloyd MD; Thompson AS; Javaid H; Martin NM; Threadgill MD
J Med Chem; 2011 Apr; 54(7):2049-59. PubMed ID: 21417348
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia.
Egi Y; Matsuura S; Maruyama T; Fujio M; Yuki S; Akira T
Brain Res; 2011 May; 1389():169-76. PubMed ID: 21420942
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of isoquinolinone-based tricycles as novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Chen J; Peng H; He J; Huan X; Miao Z; Yang C
Bioorg Med Chem Lett; 2014 Jun; 24(12):2669-73. PubMed ID: 24815508
[TBL] [Abstract][Full Text] [Related]
6. Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance.
Gerace E; Scartabelli T; Formentini L; Landucci E; Moroni F; Chiarugi A; Pellegrini-Giampietro DE
Eur J Neurosci; 2012 Jul; 36(1):1993-2005. PubMed ID: 22639866
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of isoindoloisoquinolinone, pyroloisoquinolinone and benzoquinazolinone derivatives as poly(ADP-ribose) polymerase-1 inhibitors.
Suyavaran A; Ramamurthy C; Mareeswaran R; Shanthi YV; Selvakumar J; Mangalaraj S; Kumar MS; Ramanathan CR; Thirunavukkarasu C
Bioorg Med Chem; 2015 Feb; 23(3):488-98. PubMed ID: 25555733
[TBL] [Abstract][Full Text] [Related]
8. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.
Jagtap PG; Baloglu E; Southan GJ; Mabley JG; Li H; Zhou J; van Duzer J; Salzman AL; Szabó C
J Med Chem; 2005 Aug; 48(16):5100-3. PubMed ID: 16078828
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase.
Moroni F; Cozzi A; Chiarugi A; Formentini L; Camaioni E; Pellegrini-Giampietro DE; Chen Y; Liang S; Zaleska MM; Gonzales C; Wood A; Pellicciari R
Br J Pharmacol; 2012 Mar; 165(5):1487-500. PubMed ID: 21913897
[TBL] [Abstract][Full Text] [Related]
11. Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure.
Canan Koch SS; Thoresen LH; Tikhe JG; Maegley KA; Almassy RJ; Li J; Yu XH; Zook SE; Kumpf RA; Zhang C; Boritzki TJ; Mansour RN; Zhang KE; Ekker A; Calabrese CR; Curtin NJ; Kyle S; Thomas HD; Wang LZ; Calvert AH; Golding BT; Griffin RJ; Newell DR; Webber SE; Hostomsky Z
J Med Chem; 2002 Nov; 45(23):4961-74. PubMed ID: 12408707
[TBL] [Abstract][Full Text] [Related]
12. On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives.
Pellicciari R; Camaioni E; Costantino G; Formentini L; Sabbatini P; Venturoni F; Eren G; Bellocchi D; Chiarugi A; Moroni F
ChemMedChem; 2008 Jun; 3(6):914-23. PubMed ID: 18409175
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia.
Moroni F; Meli E; Peruginelli F; Chiarugi A; Cozzi A; Picca R; Romagnoli P; Pellicciari R; Pellegrini-Giampietro DE
Cell Death Differ; 2001 Sep; 8(9):921-32. PubMed ID: 11526447
[TBL] [Abstract][Full Text] [Related]
14. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
[TBL] [Abstract][Full Text] [Related]
15. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of poly (ADP-ribose) polymerase inhibitors in transient focal cerebral ischemia of rats.
Sun AY; Cheng JS
Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):104-8. PubMed ID: 10374629
[TBL] [Abstract][Full Text] [Related]
17. GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase.
Zhang J; Lautar S; Huang S; Ramsey C; Cheung A; Li JH
Biochem Biophys Res Commun; 2000 Nov; 278(3):590-8. PubMed ID: 11095954
[TBL] [Abstract][Full Text] [Related]
18. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors.
Giovannelli L; Cozzi A; Guarnieri I; Dolara P; Moroni F
J Cereb Blood Flow Metab; 2002 Jun; 22(6):697-704. PubMed ID: 12045668
[TBL] [Abstract][Full Text] [Related]
19. [Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase].
Boulu RG; Mesenge C; Charriaut-Marlangue C; Verrecchia C; Plotkine M
Bull Acad Natl Med; 2001; 185(3):555-63; discussion 564-5. PubMed ID: 11501263
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitor.
Sunderland PT; Dhami A; Mahon MF; Jones LA; Tully SR; Lloyd MD; Thompson AS; Javaid H; Martin NM; Threadgill MD
Org Biomol Chem; 2011 Feb; 9(3):881-91. PubMed ID: 21127791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
